JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M403595200 on May 17, 2004

J. Biol. Chem., Vol. 279, Issue 29, 30219-30227, July 16, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/29/30219    most recent
M403595200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colvin, R. A.
Right arrow Articles by Luster, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colvin, R. A.
Right arrow Articles by Luster, A. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Intracellular Domains of CXCR3 That Mediate CXCL9, CXCL10, and CXCL11 Function*

Richard A. Colvin, Gabriele S. V. Campanella, Jieti Sun, and Andrew D. Luster{ddagger}

From the Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts 02129

The chemokine receptor CXCR3 is a G protein-coupled receptor found predominantly on T cells that is activated by three ligands as follows: CXCL9 (Mig), CXCL10 (IP-10), and CXCL11 (I-TAC). Previously, we have found that of the three ligands, CXCL11 is the most potent inducer of CXCR3 internalization and is the physiologic inducer of CXCR3 internalization after T cell contact with activated endothelial cells. We have therefore hypothesized that these three ligands transduce different signals to CXCR3. In light of this hypothesis, we sought to determine whether regions of CXCR3 are differentially required for CXCL9, CXCL10, and CXCL11 function. Here we identified two distinct domains that contributed to CXCR3 internalization. The carboxyl-terminal domain and {beta}-arrestin1 were predominantly required by CXCL9 and CXCL10, and the third intracellular loop was predominantly required by CXCL11. Chemotaxis and calcium mobilization induced by all three CXCR3 ligands were dependent on the CXCR3 carboxyl terminus and the DRY sequence in the third trans-membrane domain. Our findings demonstrate that distinct domains of CXCR3 mediate its functions and suggest that the differential requirement of these domains contributes to the complexity of the chemokine system.


Received for publication, March 31, 2004 , and in revised form, May 7, 2004.

* This work was supported by National Institutes of Health Grants K08 AI50147 (to R. A. C.), PO1 DK50305, and R01 CA69212 (to A. D. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed: Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, 149 Thirteenth St., Rm. 8031, Charlestown, MA 02129. Tel.: 617-726-5710; Fax: 617-726-5651; E-mail: aluster{at}partners.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Meiser, A. Mueller, E. L. Wise, E. M. McDonagh, S. J. Petit, N. Saran, P. C. Clark, T. J. Williams, and J. E. Pease
The Chemokine Receptor CXCR3 Is Degraded following Internalization and Is Replenished at the Cell Surface by De Novo Synthesis of Receptor
J. Immunol., May 15, 2008; 180(10): 6713 - 6724.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Xia, A. O'Hara, I. Araujo, J. Barreto, E. Carvalho, J. B. Sapucaia, J. C. Ramos, E. Luz, C. Pedroso, M. Manrique, et al.
EBV MicroRNAs in Primary Lymphomas and Targeting of CXCL-11 by ebv-mir-BHRF1-3
Cancer Res., March 1, 2008; 68(5): 1436 - 1442.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Loeffler, G. Le'Negrate, M. Krajewska, and J. C. Reed
Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth
PNAS, July 31, 2007; 104(31): 12879 - 12883.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G. R. de Arquer, R. Pena, C. Cabrera, G. Coma, R. Ruiz-Hernandez, R. Guerola, B. Clotet, L. Ruiz, J. A. Este, M. L. Calle, et al.
Skewed expression and up-regulation of the IL-12 and IL-18 receptors in resting and activated CD4 T cells from HIV-1-infected patients
J. Leukoc. Biol., July 1, 2007; 82(1): 72 - 78.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
N. F. Neel, L. A. Lapierre, J. R. Goldenring, and A. Richmond
RhoB plays an essential role in CXCR2 sorting decisions
J. Cell Sci., May 1, 2007; 120(9): 1559 - 1571.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. D. Thompson, Y. Jin, K. H. Wu, R. A. Colvin, A. D. Luster, L. Birnbaumer, and M. X. Wu
Inhibition of G{alpha}i2 Activation by G{alpha}i3 in CXCR3-mediated Signaling
J. Biol. Chem., March 30, 2007; 282(13): 9547 - 9555.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. M. Dame, B. L. Orenzoff, L. E. Palmer, and M. B. Furie
IFN-{gamma} Alters the Response of Borrelia burgdorferi-Activated Endothelium to Favor Chronic Inflammation
J. Immunol., January 15, 2007; 178(2): 1172 - 1179.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. S. V. Campanella, J. Grimm, L. A. Manice, R. A. Colvin, B. D. Medoff, G. R. Wojtkiewicz, R. Weissleder, and A. D. Luster
Oligomerization of CXCL10 Is Necessary for Endothelial Cell Presentation and In Vivo Activity
J. Immunol., November 15, 2006; 177(10): 6991 - 6998.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. R. Taqueti, N. Grabie, R. Colvin, H. Pang, P. Jarolim, A. D. Luster, L. H. Glimcher, and A. H. Lichtman
T-bet Controls Pathogenicity of CTLs in the Heart by Separable Effects on Migration and Effector Activity
J. Immunol., November 1, 2006; 177(9): 5890 - 5901.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. A. Colvin, G. S. V. Campanella, L. A. Manice, and A. D. Luster
CXCR3 Requires Tyrosine Sulfation for Ligand Binding and a Second Extracellular Loop Arginine Residue for Ligand-Induced Chemotaxis
Mol. Cell. Biol., August 1, 2006; 26(15): 5838 - 5849.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. N. Renn, D. J. Sanchez, M. T. Ochoa, A. J. Legaspi, C.-K. Oh, P. T. Liu, S. R. Krutzik, P. A. Sieling, G. Cheng, and R. L. Modlin
TLR Activation of Langerhans Cell-Like Dendritic Cells Triggers an Antiviral Immune Response
J. Immunol., July 1, 2006; 177(1): 298 - 305.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Dagan-Berger, R. Feniger-Barish, S. Avniel, H. Wald, E. Galun, V. Grabovsky, R. Alon, A. Nagler, A. Ben-Baruch, and A. Peled
Role of CXCR3 carboxyl terminus and third intracellular loop in receptor-mediated migration, adhesion and internalization in response to CXCL11
Blood, May 15, 2006; 107(10): 3821 - 3831.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Rahangdale, R. Morgan, C. Heijens, T. C. Ryan, H. Yamasaki, E. Bentley, E. Sullivan, D. M. Center, and W. W. Cruikshank
Chemokine Receptor CXCR3 Desensitization by IL-16/CD4 Signaling Is Dependent on CCR5 and Intact Membrane Cholesterol
J. Immunol., February 15, 2006; 176(4): 2337 - 2345.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Sfriso, F. Oliviero, F. Calabrese, M. Miorin, M. Facco, A. Contri, A. Cabrelle, I. Baesso, F. Cozzi, M. Andretta, et al.
Epithelial CXCR3-B Regulates Chemokines Bioavailability in Normal, but Not in Sjogren's Syndrome, Salivary Glands
J. Immunol., February 15, 2006; 176(4): 2581 - 2589.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
B. D. Medoff, E. Seung, J. C. Wain, T. K. Means, G. S.V. Campanella, S. A. Islam, S. Y. Thomas, L. C. Ginns, N. Grabie, A. H. Lichtman, et al.
BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation
J. Exp. Med., July 5, 2005; 202(1): 97 - 110.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Perry, S. Junger, T. A. Kohout, S. R. J. Hoare, R. S. Struthers, D. E. Grigoriadis, and R. A. Maki
Distinct Conformations of the Corticotropin Releasing Factor Type 1 Receptor Adopted following Agonist and Antagonist Binding Are Differentially Regulated
J. Biol. Chem., March 25, 2005; 280(12): 11560 - 11568.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.